Latest Blogs

Guest Commentary
Mar 21, 2023
My Journey Through the Hematology / Oncology Fellowship Match
Dr. Michael LaPelusa shares his recent start-to-finish experience going through the Fellowship Match, with tips for preparing your application, interviewing, and telling your unique professional story.
Guest Commentary
Mar 16, 2023
Set Up Your Collaborative Team for Success: A Guideline for Advanced Practice Provider/Physician Team-Based Care in Oncology
Clear expectations are key for effective teamwork. Tammy Triglianos, Dr. Ethan Basch, and Dr. Matthew Milowsky share a guidance document to facilitate excellent collaboration in advanced practice provider/physician teams.
Guest Commentary
Mar 14, 2023
Geriatric Oncology: A Training Opportunity That Has Come of Age
Four geriatric oncology experts answer five questions about the field, including what oncology trainees need to know, how to pursue consolidated training, and why geriatric oncology is a meaningful and rewarding career.
International Perspectives
Mar 14, 2023
I Travel for Global Oncology: The Tale of My Great Journey at the University of Lahore in Pakistan
Dr. Khalid El Bairi was invited to participate in the International Summit of Health Professionals in Pakistan, a country he only knew from the news and nature documentaries. The visit challenged his perceptions and allowed him to make valuable connections.
Subscribe to this column

Edward P. Balaban, FACP, DO, FASCO

Edward P. Balaban, DO, FACP, FASCO, is the medical director for the Cancer Care Partnership with Penn State University Cancer Institute and professor of medicine at Penn State Hershey Cancer Institute. He has served as a Practice Guideline Implementation Network (PGIN) representative for Weight-Based Dosing Chemotherapy for Cancer Patients and Gastrointestinal Guideline Advisory Groups. Dr. Balaban is past president of the Pennsylvania Society of Oncology and Hematology. He serves as an ASCO delegate to the American Medical Association House of Delegates (AMA HOD).

Disclosure.

Jun 22, 2016
So Much Done, So Much More to Do: AMA House of Delegates Report
ASCO composed and successfully brought to the AMA-HOD several resolutions representing some of our most pressing concerns and/or initiatives, including regulations on handling hazardous materials, transparency on clinical pathways, reimbursement models, and Part B drug payments.
Jan 05, 2016
AMA House of Delegates: A Glimpse into the Future
ASCO staff and  member representatives gathered in Atlanta for the AMA House of Delegates' recent meeting, and, as usual, listened, learned, and spoke on a number of topics.
Jun 18, 2015
It’s Good to Grow—with the AMA-HOD
The AMA House of Delegates (AMA-HOD) convened a few days after the ASCO Annual Meeting.  It was, in many ways, a continuation of many of the concerns reviewed at the annual ASCO gathering. The delegation representing ASCO is now composed of ASCO staff, along with Drs. Thomas Marsland, Ray Page,...
Jun 01, 2015
Much To Do and More To Come
The annual ASCO gathering is now in its last 48 hours, and it has been interesting. I have heard discussions concerning payment reform, oncology medical homes, and value based care. The highlighted plenary presentations concerning what appears to be a major clinical advance in the treatment of...
Nov 25, 2014
The AMA House of Delegates Update: “And in the End. . . ”
The American Medical Association House of Delegates (AMA HOD) met once again last week in Dallas, Texas. This was the interim meeting where we welcomed ASCO’s new alternate delegate Dr. Kristina Maletz. As always, a wide variety of reports and resolutions were proposed. ...
Jun 26, 2014
The AMA House of Delegates: We Have a Lot to Discuss
We just returned from the American Medical Association (AMA) House of Delegates (HOD) gathering. Once again, it proved to be extensive, revealing, and eventful. ASCO’s Dr. Barbara McAneny was reelected to the AMA...

Pages